Tue, September 10, 2024

David Nierengarten Reiterated (YMAB) at Buy and Held Target at $23 on, Sep 10th, 2024

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-23-on-sep-10th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
David Nierengarten of Wedbush, Reiterated "Y-mAbs Therapeutics, Inc." (YMAB) at Buy and Held Target at $23 on, Sep 10th, 2024.

David has made no other calls on YMAB in the last 4 months.



There are 7 other peers that have a rating on YMAB. Out of the 7 peers that are also analyzing YMAB, 0 agree with David's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with David


  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $20 on, Monday, September 9th, 2024
  • Michael Ulz of "Morgan Stanley" Maintained at Sell with Decreased Target to $11 on, Tuesday, August 13th, 2024
  • Bill Maughan of "Canaccord Genuity" Maintained at Strong Buy and Held Target at $26 on, Tuesday, August 13th, 2024
  • Etzer Darout of "BMO Capital" Maintained at Buy with Decreased Target to $25 on, Tuesday, August 13th, 2024
  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $22 on, Tuesday, August 13th, 2024
  • Justin Walsh of "Jones Trading" Initiated at Strong Buy and Held Target at $23 on, Thursday, July 11th, 2024
  • Nicole Germino of "Truist Securities" Initiated at Strong Buy and Held Target at $21 on, Friday, June 28th, 2024